Melanoma

The samples sequenced include brain, lymph, primary and metastatic tumours as well as cell line derived samples. The following coverage levels were generated for each sample:

60x (or greater) for tumour samples

40x for cell line samples

40x for control blood samples

Partner organisations include:

Melanoma Institute Australia

John Curtin School of Medical Research, ANU

Berghofer Queensland Institute of Medical Research

University of Sydney

Harry Perkins Institute of Medical Research

Peter MacCallum Cancer Centre

Ludwig Institute for Cancer Research

University of Queensland

Cancer Council NSW

The project is now part of the International Cancer Genome Consortium.
For further information on the data and access to the somatic variants for this study, go to: http://icgc.org/icgc/cgp/71/304/1012257

Due to ethics requirements, this data is only available upon request to the collaborators by authenticated researchers. This data has been made available through the International Cancer Genome Consortium.
https://dcc.icgc.org/projects/MELA-AU